Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris

Seagen did not address rumors of a buyout from Merck during its fourth-quarter and full-year financial report Wednesday.

Instead, the Washington-based biotech focused on upcoming label expansions and its promising pipeline.